T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Myers Industries
MYE
$1.23B
| $61.6M | 0.01% |
4,275,716
+178,568
| +4% | +$2.48M |
|
702
BWX Technologies
BWXT
$15.8B
| $61.6M | 0.01% |
1,720,976
+72,192
| +4% | +$2.47M |
|
703
America Movil
AMX
$69.7B
| $61.5M | 0.01% |
5,015,690
-386,120
| -7% | -$5.17M |
|
704
Aflac
AFL
$60.5B
| $61.3M | 0.01% |
1,698,408
-7,158
| -0.4% | -$244K |
|
|
HSNI
705
DELISTED
HSN, Inc.
HSNI
| $61.2M | 0.01% |
1,251,774
+4,570
| +0.4% | +$234K |
|
706
Kearny Financial
KRNY
$600M
| $61.1M | 0.01% |
4,858,388
+1,302,209
| +37% | +$16.7M |
|
|
FNGN
707
DELISTED
Financial Engines, Inc.
FNGN
| $61M | 0.01% |
2,358,980
-867,296
| -27% | -$24.9M |
|
|
KLXI
708
DELISTED
KLX Inc.
KLXI
| $60.8M | 0.01% |
2,324,835
+129,143
| +6% | +$3.55M |
|
|
BMS
709
DELISTED
Bemis
BMS
| $60.7M | 0.01% |
1,179,180
+400,160
| +51% | +$20.2M |
|
710
Cavco Industries
CVCO
$4.6B
| $60.7M | 0.01% |
647,960
-2,900
| -0.4% | -$267K |
|
711
Sempra
SRE
$56.2B
| $60.7M | 0.01% |
1,064,458
-475,912
| -31% | -$25.2M |
|
712
Ligand Pharmaceuticals
LGND
$5.85B
| $60.4M | 0.01% |
811,419
+24,461
| +3% | +$1.82M |
|
713
Pinnacle Financial Partners Inc
PNFP
$16.1B
| $60.1M | 0.01% |
1,229,982
+162,406
| +15% | +$7.95M |
|
|
ULTI
714
DELISTED
Ultimate Software Group Inc
ULTI
| $59.8M | 0.01% |
284,343
-45,586
| -14% | -$9.05M |
|
715
California Water Service
CWT
$3.09B
| $59.7M | 0.01% |
1,709,893
+1,677,800
| +5,228% | +$49.2M |
|
716
Kirby Corp
KEX
$7.18B
| $59.7M | 0.01% |
957,213
-160,117
| -14% | -$10.5M |
|
|
UBNK
717
DELISTED
United Financial Bancorp, Inc.
UBNK
| $59.6M | 0.01% |
4,588,404
+804,910
| +21% | +$10.4M |
|
|
WGL
718
DELISTED
Wgl Holdings
WGL
| $59.3M | 0.01% |
838,017
-91,116
| -10% | -$6.17M |
|
719
Graphic Packaging
GPK
$3.46B
| $59.2M | 0.01% |
4,718,094
+2,977,898
| +171% | +$38.9M |
|
720
FIVE9
FIVN
$2.33B
| $58.9M | 0.01% |
4,951,350
+193,790
| +4% | +$1.96M |
|
721
Boston Scientific
BSX
$74.5B
| $58.5M | 0.01% |
2,503,663
+57,620
| +2% | +$1.25M |
|
|
EBSB
722
DELISTED
Meridian Bancorp, Inc.
EBSB
| $58.5M | 0.01% |
3,955,376
+149,796
| +4% | +$2.18M |
|
723
M&T Bank
MTB
$36.6B
| $58.2M | 0.01% |
491,933
+6,230
| +1% | +$723K |
|
|
HMSY
724
DELISTED
HMS Holdings Corp.
HMSY
| $58.1M | 0.01% |
3,297,858
+993,260
| +43% | +$16M |
|
725
Prudential Financial
PRU
$42.3B
| $58M | 0.01% |
812,970
-4,700
| -0.6% | -$355K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.